RYAN DONLON: Open Payments
NPI 1023609401 · MURRIETA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,505 in 70 payments from 13 companies in 2025. Trend: 2023 $2,325 · 2024 $1,683 · 2025 $1,505
Food & beverage: $1,420Education: $85
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 9 | $270 |
| UCB, Inc. | 17 | $250 |
| Amgen Inc. | 13 | $172 |
| Galderma Laboratories, L.P. | 3 | $166 |
| LEO Pharma Inc. | 8 | $143 |
| Janssen Biotech, Inc. | 5 | $91 |
| Novartis Pharmaceuticals Corporation | 4 | $87 |
| Regeneron Healthcare Solutions, Inc. | 1 | $85 |
| ABBVIE INC. | 3 | $74 |
| Arcutis Biotherapeutics, Inc. | 3 | $65 |
Products named: DUPIXENT, Bimzelx, Otezla, NEMLUVIO, ADBRY, TREMFYA, Rhapsido, Zoryve.
Industry payments across CA — which companies pay providers there.
